JAK2変異体のシグナル伝達解析による真性赤血球増加症発症機構の解明
スポンサーリンク
概要
- 論文の詳細を見る
It has been well established that disruption of JAK2 signaling regulation is involved in various hematopoietic disorders; however, the detailed mechanism by which abnormal activation of JAK2 exhibits transforming activity remains to be elucidated. The somatic JAK2 mutation (V617F) was identified in most patients with polycythemia vera (PV). Here, we show that JAK2 V617F mutant was constitutively active and exhibited tumorigenesis activity as a potent oncogene when erythropoietin receptor (EpoR) was co-expressed. To clarify the signaling pathway of JAK2 V617F mutant, we investigated the functional role of downstream transcription factor STAT5 in its induced cellular transformation and tumorigenesis in nude mice. Interestingly, JAK2 V617F mutant failed to exhibit transforming activity when STAT5 activation was inhibited utilizing EpoR mutant (HM). Furthermore, the expression of constitutively active STAT5 mutant (1*6) exhibited transforming activity. Taking these observations together, it is concluded STAT5 plays an essential role in EpoR-JAK2 V617F mutant-induced hematopoietic disorder and would be a good target for the treatment of PV.
論文 | ランダム
- 青年時代のモリエール : 『相いれないもののバレエ』についての一考察
- 『ボードレール』におけるサルトル的戦略
- モンテーニュ、見上げる目、見下ろす目 (1)
- 日欧語比較文体論の試みVI : 比較文章論-自動詞と他動詞
- バンジャマン・コンスタン『日記』(II)